| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accelerated partial breast irradiation with perioperative multicatheter interstitial brachytherapy—A feasibility study
|
Pohanková, Denisa
|
|
2018
|
17 |
6 |
p. 949-955
|
article
|
| 2 |
A novel rectal applicator for contact radiotherapy with HDR 192Ir sources
|
Bellezzo, Murillo
|
|
2018
|
17 |
6 |
p. 1037-1044
|
article
|
| 3 |
A revised dosimetric characterization of 60Co BEBIG source: From single-source data to clinical dose distribution
|
Abdollahi, Sara
|
|
2018
|
17 |
6 |
p. 1011-1022
|
article
|
| 4 |
Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities
|
Patel, Ravi B.
|
|
2018
|
17 |
6 |
p. 995-1003
|
article
|
| 5 |
Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer
|
Vu, Charles C.
|
|
2018
|
17 |
6 |
p. 852-857
|
article
|
| 6 |
Declining brachytherapy utilization for high-risk prostate cancer—Can clinical pathways reverse the trend?
|
Ling, Diane C.
|
|
2018
|
17 |
6 |
p. 895-898
|
article
|
| 7 |
Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
|
Nieto, Karina
|
|
2018
|
17 |
6 |
p. 929-934
|
article
|
| 8 |
Does postoperative irradiation improve survival in early-stage endometrial cancer?
|
Sabater, Sebastia
|
|
2018
|
17 |
6 |
p. 912-921
|
article
|
| 9 |
Editorial Board
|
|
|
2018
|
17 |
6 |
p. A5
|
article
|
| 10 |
Endobronchial brachytherapy—A novel approach for the management of airway amyloidosis
|
Moore, Assaf
|
|
2018
|
17 |
6 |
p. 966-972
|
article
|
| 11 |
Endobronchial brachytherapy in the management of lung malignancies: 20 years of experience in an Australian center
|
Knox, Matthew C.
|
|
2018
|
17 |
6 |
p. 973-980
|
article
|
| 12 |
Evaluation of effective treatment depth in skin cancer treatments with electronic brachytherapy
|
Lloyd, Samantha A.M.
|
|
2018
|
17 |
6 |
p. 990-994
|
article
|
| 13 |
High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results
|
Prada, Pedro J.
|
|
2018
|
17 |
6 |
p. 845-851
|
article
|
| 14 |
High-volume providers and brachytherapy practice: A Medicare provider utilization and payment analysis
|
Hong, Julian C.
|
|
2018
|
17 |
6 |
p. 906-911
|
article
|
| 15 |
Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images
|
Girum, Kibrom Berihu
|
|
2018
|
17 |
6 |
p. 866-873
|
article
|
| 16 |
Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer
|
Agarwal, Manuj
|
|
2018
|
17 |
6 |
p. 882-887
|
article
|
| 17 |
Masthead
|
|
|
2018
|
17 |
6 |
p. A1
|
article
|
| 18 |
Modeling of the direction modulated brachytherapy tandem applicator using the Oncentra Brachy advanced collapsed cone engine
|
Safigholi, Habib
|
|
2018
|
17 |
6 |
p. 1030-1036
|
article
|
| 19 |
Multi-institutional evaluation of the reproducibility and the accuracy of the objective breast cosmesis scale
|
Lancellotta, Valentina
|
|
2018
|
17 |
6 |
p. 944-948
|
article
|
| 20 |
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer
|
Annede, Pierre
|
|
2018
|
17 |
6 |
p. 922-928
|
article
|
| 21 |
Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review
|
Le, Bao Han A.
|
|
2018
|
17 |
6 |
p. 981-989
|
article
|
| 22 |
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial
|
Martínez-Monge, Rafael
|
|
2018
|
17 |
6 |
p. 1045
|
article
|
| 23 |
Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy
|
Lee, Junghoon
|
|
2018
|
17 |
6 |
p. 858-865
|
article
|
| 24 |
Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer
|
Palhares, Daniel Moore Freitas
|
|
2018
|
17 |
6 |
p. 935-943
|
article
|
| 25 |
Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor
|
Charret, J.
|
|
2018
|
17 |
6 |
p. 888-894
|
article
|
| 26 |
Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy
|
Resende Salgado, Lucas
|
|
2018
|
17 |
6 |
p. 874-881
|
article
|
| 27 |
Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial
|
Belley, Matthew D.
|
|
2018
|
17 |
6 |
p. 1023-1029
|
article
|
| 28 |
Reviewers Listing 2018
|
|
|
2018
|
17 |
6 |
p. 1046-1047
|
article
|
| 29 |
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy
|
Niwa, Naoya
|
|
2018
|
17 |
6 |
p. 899-905
|
article
|
| 30 |
Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy
|
Huang, YuHuei Jessica
|
|
2018
|
17 |
6 |
p. 956-965
|
article
|
| 31 |
Table of Contents
|
|
|
2018
|
17 |
6 |
p. A2-A4
|
article
|
| 32 |
Twitter and brachytherapy: An analysis of “tweets” over six years by patients and health care professionals
|
Thomas, Joel
|
|
2018
|
17 |
6 |
p. 1004-1010
|
article
|
| 33 |
Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial
|
Morris, W. James
|
|
2018
|
17 |
6 |
p. 837-844
|
article
|
Journal description